0001602462-17-000001.txt : 20170627 0001602462-17-000001.hdr.sgml : 20170627 20170627131356 ACCESSION NUMBER: 0001602462-17-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170627 DATE AS OF CHANGE: 20170627 EFFECTIVENESS DATE: 20170627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KinDex Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001602462 IRS NUMBER: 270767031 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-269780 FILM NUMBER: 17931804 BUSINESS ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: (206) 447-1455 MAIL ADDRESS: STREET 1: 800 FIFTH AVENUE STREET 2: STE. 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D/A 1 primary_doc.xml X0707 D/A LIVE 0001602462 KinDex Pharmaceuticals, Inc. 800 FIFTH AVENUE STE. 4100 SEATTLE WA WASHINGTON 98104 (206) 447-1455 DELAWARE KinDex Therapeutics, LLC None Corporation true Jeffrey S Bland 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Brent Eck 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Jeffrey J Katke 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Paul Schimmel 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Lincoln Bouillon 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Michael Higgins 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Neile A Grayson 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Dennis Ausiello 800 Fifth Avenue Suite 4100 Seattle WA WASHINGTON 98104 Director Pharmaceuticals Decline to Disclose 06b true 0001602462-16-000002 2016-08-16 false true true true false 0 1300001 1054546 245455 false 6 0 0 0 false KinDex Pharmaceuticals, Inc. /s/ Lincoln Bouillon Lincoln Bouillon Chief Financial Officer 2017-06-21